Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be at Booth F18 at the CIRSE 2023 Conference, September 9 – 13 in Copenhagen, Denmark.  They are excited to discuss how Immunophotonics is advancing the novel concept of abscopalizing routine tumor destruction procedures.